GSA Capital Partners’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-88,233
| Closed | -$25K | – | 1734 |
|
|
2025
Q1 | $25K | Sell |
88,233
-208,323
| -70% | -$59K | ﹤0.01% | 1576 |
|
|
2024
Q4 | $174K | Sell |
296,556
-100,555
| -25% | -$59K | 0.01% | 1443 |
|
|
2024
Q3 | $177K | Buy |
397,111
+357,787
| +910% | +$159K | 0.01% | 1434 |
|
|
2024
Q2 | $104K | Sell |
39,324
-136,906
| -78% | -$362K | 0.01% | 1527 |
|
|
2024
Q1 | $483K | Sell |
176,230
-124,621
| -41% | -$342K | 0.04% | 906 |
|
|
2023
Q4 | $731K | Buy |
300,851
+3,799
| +1% | +$9.23K | 0.06% | 565 |
|
|
2023
Q3 | $600K | Sell |
297,052
-49,379
| -14% | -$99.7K | 0.05% | 680 |
|
|
2023
Q2 | $1.02M | Sell |
346,431
-13,811
| -4% | -$40.7K | 0.1% | 301 |
|
|
2023
Q1 | $901K | Buy |
360,242
+89,253
| +33% | +$223K | 0.09% | 371 |
|
|
2022
Q4 | $859K | Buy |
270,989
+101,471
| +60% | +$322K | 0.11% | 281 |
|
|
2022
Q3 | $503K | Buy |
+169,518
| New | +$503K | 0.07% | 566 |
|